Immune dysregulation in myelodysplastic syndrome by Chiharu Sugimori, Alan F. List, Pearlie K. Epling-Burnette

Get full text

Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of Myelofibrosis. by Ying Han, Lanzhu Yue, Max Wei, Xiubao Ren, Zonghong Shao, Ling Zhang, Ross L Levine, Pearlie K Epling-Burnette

Get full text

Bone marrow mononuclear cells up-regulate toll-like receptor expression and produce inflammatory mediators in response to cigarette smoke extract. by Junmin Zhou, Erika A Eksioglu, Nicole R Fortenbery, Xianghong Chen, Huaquan Wang, Pearlie K Epling-Burnette, Julie Y Djeu, Sheng Wei

Get full text

The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN by Lucia Mazzacurati, Robert J. Collins, Garima Pandey, Que T. Lambert-Showers, Narmin E. Amin, Ling Zhang, Matthew C. Stubbs, Pearlie K. Epling-Burnette, Holly K. Koblish, Gary W. Reuther

Get full text

A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction by Rami S. Komrokji, Adam W. Mailloux, Dung-Tsa Chen, Mikkael A. Sekeres, Ronald Paquette, William J. Fulp, Chiharu Sugimori, Jennifer Paleveda-Pena, Jaroslaw P. Maciejewski, Alan F. List, Pearlie K. Epling-Burnette

Get full text

Modulating the polyamine/hypusine axis controls generation of CD8+ tissue-resident memory T cells by Aya G. Elmarsafawi, Rebecca S. Hesterberg, Mario R. Fernandez, Chunying Yang, Lancia N.F. Darville, Min Liu, John M. Koomen, Otto Phanstiel IV, Reginald Atkins, John E. Mullinax, Shari A. Pilon-Thomas, Frederick L. Locke, Pearlie K. Epling-Burnette, John L. Cleveland

Get full text